Reaction
Lip Pruritus reporting signals
As of the last recalculation, Lip Pruritus appears in 828 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 60.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dimenhydrinate | 25 | 60.8 | 60.9 |
| Ciclesonide | 21 | 39.7 | 39.8 |
| Standardized Senna Concentrate | 19 | 38.8 | 38.9 |
| Glycerin, Lidocaine | 21 | 38.7 | 38.7 |
| Docosanol | 21 | 36.9 | 37.0 |
| Ursosiol | 22 | 29.2 | 29.2 |
| Mometasone | 20 | 28.1 | 28.1 |
| Ursodiol | 22 | 26.1 | 26.1 |
| Amitriptyline Hydrochloride | 17 | 24.8 | 24.9 |
| Eptinezumab-Jjmr | 8 | 22.3 | 22.3 |
| Iohexol | 5 | 15.2 | 15.3 |
| Mepolizumab | 22 | 11.4 | 11.4 |
| Vibegron | 3 | 9.4 | 9.4 |
| Diroximel Fumarate | 4 | 8.5 | 8.5 |
| Crisaborole | 3 | 7.9 | 7.9 |
| Fremanezumab-Vfrm | 3 | 6.6 | 6.6 |
| Dupilumab | 83 | 4.7 | 4.7 |